Infinity Pharmaceuticals reported $-12018000 in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Amgen AMGN:US $ 2176M 324M
AstraZeneca AZN:LN 44.27B 22.58B
Bristol Myers Squibb BMY:US $ 2590M 37M
Cytori Therapeutics CYTX:US $ -5120000 1.19M
Eisai 4523:JP Y 7434M 28237M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Genocea Biosciences GNCA:US $ -15.77M 2.36M
Gilead Sciences GILD:US $ 2029M 1832M
GlaxoSmithKline GSK:LN 108.1B 121.2B
Infinity Pharmaceuticals INFI:US $ -12.02M 0.39M
Johnson & Johnson JNJ:US $ 5840M 22M
Mirati Therapeutics MRTX:US $ -177.2M 7.01M
Novartis NOVN:VX 2.23B 624M
Pfizer PFE:US $ 12102M 2229M
Seattle Genetics SGEN:US $ -133.11M 0.06M
Tg Therapeutics TGTX:US $ -38.94M 27.93M
Vascular Biogenics VBLT:US -9614000 950K
YTE INCY:US $ 254.43M 137.89M